Treatment for non small cell lung cancer, small cell lung cancer and pleural mesothelioma within the EORTC Lung Cancer Group: past, present and future-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Treatment for non small cell lung cancer, small cell lung cancer and pleural mesothelioma within the EORTC Lung Cancer Group: past, present and future

Published:2012-03 Issue:1 Volume:10 Page:99-104
ISSN:1359-6349
Container-title:European Journal of Cancer Supplements
language:en
Short-container-title:European Journal of Cancer Supplements

Author:

O'Brien Mary E.R.,van Meerbeeck Jan P.,Surmont Veerle F.,Finn Corinne Faivre

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference37 articles.

1. Overview of past, present and future of the EORTC Lung Cancer Group;Debruyne;Eur J Cancer,2002

2. Carboplatin and paclitaxol (Taxol) as an induction regimen for patients with biopsy-proven stage IIIAN2 non-small cell lung cancer: An EORTC phase II study (EORTC 08958);O'Brien;Eur J Cancer,2003

3. Randomized trial of surgery versus radiotherapy in patients with stage IIIA (N2) non small-cell lung cancer after a response to induction chemotherapy. EORTC 08941;Splinter;Clin Lung Cancer,2000

4. Randomized study of paclitaxel-cisplatin versus cisplatin-teniposide in patients with advanced non-small-cell lung cancer. The European Organization for Research and Treatment of Cancer Lung Cancer Cooperative Group;Giaccone;J Clin Oncol,1998

5. Guidelines of the ERS/ESTS for management of malignant pleural mesothelioma;Scherpereel;Eur Resp J,2010

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP